Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF
US ˙ ARCA

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Robert F Apple. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Robert F Apple har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ATRS / Antares Pharma Inc President and CEO, Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Robert F Apple. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2016-03-18 ATRS APPLE ROBERT F 60.000 0,7200 60.000 0,7200 43.200 363 2.82 126.000 291,67

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
Insidersalg AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2019-12-10 ATRS APPLE ROBERT F 58.524 4,7563 58.524 4,7563 278.358 99 1.75 -175.940 -63,21
2019-12-09 ATRS APPLE ROBERT F 100.000 4,6783 100.000 4,6783 467.830
2019-12-09 ATRS APPLE ROBERT F 97.000 4,6228 97.000 4,6228 448.412
2019-12-09 ATRS APPLE ROBERT F 110.000 4,5766 110.000 4,5766 503.426
2019-12-09 ATRS APPLE ROBERT F 1.000 4,7500 1.000 4,7500 4.750

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Robert F Apple som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -474.629 0 -100,00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -776.617 0 -100,00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -567.423 0 -100,00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -591.510 0 -100,00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -725.751 0 -100,00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -773.700 0 -100,00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -288.786 0 -100,00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -56.300 0 -100,00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -21.658 0 -100,00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -374.099 0 -100,00 5,60 -2.094.954
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -611.667 0 -100,00 5,60 -3.425.335
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -1.876.693 0 -100,00 5,60 -10.509.481
2022-03-04 2022-03-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -37.695 2.488.360 -1,49 3,80 -143.241 9.455.768
2022-03-04 2022-03-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 86.814 2.526.055 3,56
2022-02-18 2022-02-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -34.282 2.439.241 -1,39 3,66 -125.472 8.927.622
2022-02-18 2022-02-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 76.893 2.473.523 3,21
2021-06-14 2021-06-13 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -40.892 2.396.630 -1,68 4,45 -181.969 10.665.004
2021-06-14 2021-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -58.317 2.437.522 -2,34 4,45 -259.511 10.846.973
2021-06-14 2021-06-10 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 474.629 474.629
2021-06-14 2021-06-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 248.869 2.495.839 11,08 4,42 1.100.001 11.031.608
2021-06-10 2021-06-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -44.223 2.246.970 -1,93 4,39 -194.139 9.864.198
2021-03-03 2021-03-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -66.330 2.291.193 -2,81 4,50 -298.485 10.310.368
2021-03-03 2021-03-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 152.763 2.357.523 6,93
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -250.000 0 -100,00
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -241.960 2.204.760 -9,89 5,00 -1.209.800 11.023.800
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -17.844 2.446.720 -0,72 5,01 -89.398 12.258.067
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -232.156 2.464.564 -8,61 5,00 -1.160.780 12.322.820
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 250.000 2.696.720 10,22 0,88 220.000 2.373.114
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -5.519 0 -100,00
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -5.519 2.446.720 -0,23 4,75 -26.215 11.621.920
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 5.519 2.452.239 0,23 2,62 14.460 6.424.866
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -116.313 2.446.720 -4,54 4,73 -550.160 11.572.986
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 267.878 2.563.033 11,67
2021-02-10 2021-02-10 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -7.278 0 -100,00
2021-02-10 2021-02-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -7.278 2.295.155 -0,32 4,75 -34.570 10.901.986
2021-02-10 2021-02-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 7.278 2.302.433 0,32 2,62 19.068 6.032.374
2021-02-10 2021-02-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -49.129 0 -100,00
2021-02-10 2021-02-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -49.129 2.295.155 -2,10 4,75 -233.363 10.901.986
2021-02-10 2021-02-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 49.129 2.344.284 2,14 2,62 128.718 6.142.024
2021-02-10 2021-02-08 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -33.574 0 -100,00
2021-02-10 2021-02-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -33.574 2.295.155 -1,44 4,75 -159.476 10.901.986
2021-02-10 2021-02-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 33.574 2.328.729 1,46 2,62 87.964 6.101.270
2020-06-15 2020-06-13 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -40.892 2.295.155 -1,75 2,78 -113.680 6.380.531
2020-06-15 2020-06-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 776.617 776.617
2020-06-15 2020-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 402.930 2.336.047 20,84 2,73 1.099.999 6.377.408
2020-06-09 2020-06-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -44.223 1.933.117 -2,24 3,13 -138.418 6.050.656
2020-06-09 2020-06-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -48.936 1.977.340 -2,42 3,12 -152.680 6.169.301
2020-02-21 2020-02-19 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -90.397 2.026.276 -4,27 3,53 -319.101 7.152.754
2020-02-21 2020-02-19 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 210.782 2.116.673 11,06
2019-12-11 2019-12-10 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -58.524 0 -100,00
2019-12-11 2019-12-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -58.524 1.905.891 -2,98 4,76 -278.358 9.064.989
2019-12-11 2019-12-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 58.524 1.964.415 3,07 3,96 231.755 7.779.083
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -1.000 0 -100,00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -110.000 0 -100,00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -97.000 0 -100,00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -100.000 0 -100,00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -1.000 1.905.891 -0,05 4,75 -4.750 9.052.982
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 1.000 1.906.891 0,05 3,96 3.960 7.551.288
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -110.000 1.905.891 -5,46 4,58 -503.426 8.722.501
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 110.000 2.015.891 5,77 2,94 323.400 5.926.720
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -97.000 1.905.891 -4,84 4,62 -448.412 8.810.553
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 97.000 2.002.891 5,09 1,66 161.020 3.324.799
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -100.000 1.905.891 -4,99 4,68 -467.830 8.916.330
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 100.000 2.005.891 5,25 1,52 152.000 3.048.954
2019-11-13 2019-11-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -100.000 0 -100,00
2019-11-13 2019-11-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -43.445 1.905.891 -2,23 3,77 -163.788 7.185.209
2019-11-13 2019-11-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 100.000 1.949.336 5,41 1,10 110.000 2.144.270
2019-06-14 2019-06-13 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 567.423 567.423
2019-06-14 2019-06-13 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 282.534 1.849.336 18,03 2,92 824.999 5.400.061
2019-06-11 2019-06-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -44.225 1.566.802 -2,75 2,81 -124.272 4.402.714
2019-06-11 2019-06-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -48.936 1.611.027 -2,95 2,81 -137.510 4.526.986
2019-06-04 2019-06-02 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -52.559 1.659.963 -3,07 2,79 -146.640 4.631.297
2019-02-22 2019-02-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -72.245 1.712.522 -4,05 3,20 -231.184 5.480.070
2019-02-22 2019-02-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 254.205 1.784.767 16,61
2018-08-23 2018-08-21 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -43.000 0 -100,00
2018-08-23 2018-08-21 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -43.000 1.530.562 -2,73 3,75 -161.250 5.739.608
2018-08-23 2018-08-21 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 43.000 1.573.562 2,81 0,47 20.210 739.574
2018-06-11 2018-06-08 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 591.510 591.510
2018-06-11 2018-06-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 305.556 1.530.562 24,94 2,70 825.001 4.132.517
2018-06-11 2018-06-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -32.031 1.225.006 -2,55 2,70 -86.484 3.307.516
2018-06-05 2018-06-02 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -34.402 1.257.037 -2,66 2,69 -92.541 3.381.430
2018-05-30 2018-05-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -13.480 1.291.439 -1,03 2,43 -32.756 3.138.197
2018-05-14 2018-05-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -82.500 0 -100,00
2018-05-14 2018-05-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -30.052 1.304.919 -2,25 2,52 -75.731 3.288.396
2018-05-14 2018-05-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 82.500 1.334.971 6,59 0,85 70.125 1.134.725
2018-02-26 2018-02-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -37.001 1.252.471 -2,87 2,20 -81.402 2.755.436
2018-02-26 2018-02-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 113.835 1.289.472 9,68
2017-06-12 2017-06-07 4/A ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 338.115 1.175.637 40,37 2,66 899.386 3.127.194
2017-06-09 2017-06-07 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 725.751 725.751
2017-06-09 2017-06-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award -338.115 1.175.637 -22,34 2,66 -899.386 3.127.194
2017-06-09 2017-06-02 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -38.034 837.522 -4,34 2,57 -97.747 2.152.432
2017-06-09 2017-05-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3.390 875.556 -0,39 2,51 -8.509 2.197.646
2017-06-09 2017-05-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -14.903 878.946 -1,67 2,51 -37.407 2.206.154
2017-06-09 2017-02-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -1.763 893.849 -0,20 2,37 -4.178 2.118.422
2017-06-09 2017-02-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 5.612 895.612 0,63
2017-04-05 2017-04-05 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -3.000 0 -100,00
2017-04-05 2017-04-05 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -3.000 890.002 -0,34 3,00 -9.000 2.670.006
2017-04-05 2017-04-05 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 3.000 893.002 0,34 1,65 4.950 1.473.453
2017-04-05 2017-04-04 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -37.000 3.000 -92,50
2017-04-05 2017-04-04 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -37.000 890.002 -3,99 3,00 -111.070 2.671.697
2017-04-05 2017-04-04 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 37.000 927.002 4,16 1,65 61.050 1.529.553
2016-12-29 2017-12-27 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -39.717 890.002 -4,27 2,35 -93.335 2.091.505
2016-12-29 2017-12-27 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 60.000 929.719 6,90 1,23 73.800 1.143.554
2016-12-29 2016-12-27 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -60.000 0 -100,00
2016-06-30 2016-06-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 11.223 869.719 1,31 1,05 11.784 913.205
2016-06-06 2016-06-02 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 773.700 773.700
2016-06-06 2016-06-02 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 363.150 858.496 73,31 1,12 406.728 961.516
2016-06-01 2016-05-31 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3.389 495.346 -0,68 0,92 -3.118 455.718
2016-06-01 2016-05-31 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -14.903 498.735 -2,90 0,92 -13.711 458.836
2016-06-01 2016-05-31 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3.526 513.638 -0,68 0,86 -3.032 441.729
2016-03-18 2016-03-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
P - Purchase 60.000 517.164 13,12 0,72 43.200 372.358
2016-03-11 2016-03-10 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 250.000 250.000
2015-06-01 2015-05-28 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 288.786 288.786
2015-06-01 2015-05-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 142.294 457.164 45,19
2015-06-01 2015-05-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3.389 314.870 -1,06 2,18 -7.388 686.417
2015-06-01 2015-05-21 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3.526 318.259 -1,10 2,10 -7.405 668.344
2015-03-12 2015-03-10 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 95.500 95.500
2015-03-12 2015-02-10 4/A ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -4.779 355.455 -1,33 2,36 -11.278 838.874
2015-03-12 2015-02-10 4/A ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 12.519 360.234 3,60
2015-03-12 2014-05-21 4/A ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3.526 340.392 -1,03 2,97 -10.472 1.010.964
2015-02-12 2015-02-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -4.779 326.619 -1,44 2,36 -11.278 770.821
2015-02-12 2015-02-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 12.519 331.398 3,93
2014-06-02 2014-05-29 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 56.300 1.169.982 5,06
2014-06-02 2014-05-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 32.362 441.005 7,92
2014-06-02 2014-05-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 64.725 408.643 18,82
2014-02-13 2014-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -7.752 343.918 -2,20 4,45 -34.496 1.530.435
2014-02-13 2014-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -25.000 351.670 -6,64
2014-02-13 2014-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3.484 376.670 -0,92 4,45 -15.504 1.676.182
2014-02-13 2014-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 11.236 380.154 3,05
2014-01-14 2014-01-10 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -10.000 1.113.682 -0,89
2014-01-14 2014-01-10 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -10.000 368.918 -2,64 5,00 -50.000 1.844.590
2014-01-14 2014-01-10 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 10.000 378.918 2,71 0,47 4.700 178.091
2013-10-16 2013-10-14 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -22.000 1.123.682 -1,92
2013-10-16 2013-10-14 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -22.000 368.918 -5,63 5,05 -111.199 1.864.696
2013-10-16 2013-10-14 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 22.000 390.918 5,96 0,47 10.340 183.731
2013-06-05 2013-06-04 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -28.600 1.145.682 -2,44
2013-06-05 2013-06-04 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -28.600 368.918 -7,19 4,03 -115.126 1.485.043
2013-06-05 2013-06-04 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 28.600 397.518 7,75 0,47 13.442 186.833
2013-06-05 2013-06-03 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -86.400 1.174.282 -6,85
2013-06-05 2013-06-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -86.400 368.918 -18,98 4,01 -346.792 1.480.763
2013-06-05 2013-06-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 86.400 455.318 23,42 0,47 40.608 213.999
2013-05-24 2013-05-22 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 59.524 1.260.682 4,96
2013-05-24 2013-05-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 33.670 368.918 10,04
2013-05-24 2013-05-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 33.670 368.918 10,04
2013-05-08 2013-05-06 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -10.000 1.201.158 -0,83
2013-05-08 2013-05-06 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -10.000 301.578 -3,21 4,02 -40.157 1.211.047
2013-05-08 2013-05-06 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 10.000 311.578 3,32 0,47 4.700 146.442
2013-01-10 2013-01-08 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -25.000 1.211.158 -2,02
2013-01-10 2013-01-08 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -25.000 310.270 -7,46 4,01 -100.290 1.244.679
2013-01-10 2013-01-08 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 25.000 335.270 8,06 0,47 11.750 157.577
2012-12-06 2012-12-04 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -25.000 1.236.158 -1,98
2012-12-06 2012-12-04 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -25.000 310.270 -7,46 4,00 -100.000 1.241.080
2012-12-06 2012-12-04 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 25.000 335.270 8,06 0,47 11.750 157.577
2012-07-10 2012-07-06 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 21.658 1.261.158 1,75
2012-07-10 2012-07-06 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 25.039 310.270 8,78
2012-05-21 2012-05-17 4 AIS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 110.000 1.239.500 9,74
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)